Emerald Health Therapeutics, Inc. announced the appointment of Chris Wagner as Chief Executive Officer and a director of EHT. Bin Huang, PhD, will continue to focus on the management of the company's operations and expansion as President of Emerald Health Botanicals EHT's wholly owned subsidiary which is a Licensed Producer under the Canadian Access to Cannabis for Medical Purposes Regulations. Mr. Wagner most recently served as Chairman, President and CEO of Contextual Genomics Inc.